{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:12:49Z","timestamp":1791144769688,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T00:00:00Z","timestamp":1238716800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1000367","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T18:19:27Z","timestamp":1238696367000},"page":"e1000367","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":126,"title":["Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance"],"prefix":"10.1371","volume":"5","author":[{"given":"Patric","family":"Jern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay K.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature03238","article-title":"APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.","volume":"433","author":"C Esnault","year":"2005","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nri1489","article-title":"Retroviral restriction by APOBEC proteins.","volume":"4","author":"RS Harris","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nature05540","article-title":"APOBEC3 inhibits mouse mammary tumour virus replication in vivo.","volume":"445","author":"CM Okeoma","year":"2007","journal-title":"Nature"},{"key":"ref4","first-page":"121","article-title":"Reverse Transcriptase and the Generation of Retroviral DNA.","author":"A Telesnitsky","year":"1997"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.cub.2004.06.057","article-title":"Cytidine deamination of retroviral DNA by diverse APOBEC proteins.","volume":"14","author":"KN Bishop","year":"2004","journal-title":"Curr Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection.","volume":"113","author":"RS Harris","year":"2003","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.","volume":"424","author":"B Mangeat","year":"2003","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.","volume":"424","author":"H Zhang","year":"2003","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.","volume":"11","author":"Q Yu","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1093\/nar\/gkl555","article-title":"Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication.","volume":"34","author":"R Suspene","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pgen.0030183","article-title":"Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses.","volume":"3","author":"P Jern","year":"2007","journal-title":"PLoS Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.immunol.26.021607.090350","article-title":"The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements.","volume":"26","author":"YL Chiu","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"ref13","article-title":"Interactions of Murine Apobec3 and Human Apobec3g with Murine Leukemia Viruses.","author":"SJ Rulli Jr","year":"2008","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/nar\/gkh554","article-title":"APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.","volume":"32","author":"R Suspene","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref15","first-page":"135","article-title":"Using substitution probabilities to improve position-specific scoring matrices.","volume":"12","author":"JG Henikoff","year":"1996","journal-title":"Comput Appl Biosci"},{"key":"ref16","first-page":"119","article-title":"Update of the drug resistance mutations in HIV-1: 2007.","volume":"15","author":"VA Johnson","year":"2007","journal-title":"Top HIV Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4690-6-16","article-title":"APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.","volume":"6","author":"RA Russell","year":"2009","journal-title":"Retrovirology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.00395-07","article-title":"Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.","volume":"81","author":"RA Russell","year":"2007","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nbt1008-1089","article-title":"Enhancing immunity to HIV through APOBEC.","volume":"26","author":"RS Harris","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"13235","DOI":"10.1128\/JVI.00204-07","article-title":"Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.","volume":"81","author":"A Mehle","year":"2007","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nbt.1496","article-title":"Small-molecule inhibition of HIV-1 Vif.","volume":"26","author":"R Nathans","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tibs.2007.01.004","article-title":"APOBEC-mediated viral restriction: not simply editing?","volume":"32","author":"RK Holmes","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chom.2008.08.008","article-title":"Host-retrovirus arms race: trimming the budget.","volume":"4","author":"P Jern","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chom.2008.07.005","article-title":"Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.","volume":"4","author":"M OhAinle","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1097\/00002030-200409030-00022","article-title":"APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations.","volume":"18","author":"B Berkhout","year":"2004","journal-title":"Aids"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tig.2005.03.004","article-title":"Guanine-adenine bias: a general property of retroid viruses that is unrelated to host-induced hypermutation.","volume":"21","author":"V Muller","year":"2005","journal-title":"Trends Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.","volume":"105","author":"BF Keele","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1128\/JVI.00584-08","article-title":"Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.","volume":"82","author":"AE Armitage","year":"2008","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1128\/JVI.00751-08","article-title":"Hypermutation of an ancient human retrovirus by APOBEC3G.","volume":"82","author":"YN Lee","year":"2008","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-4690-5-26","article-title":"Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3).","volume":"5","author":"SK Pillai","year":"2008","journal-title":"Retrovirology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAD.0b013e3282f29478","article-title":"Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase.","volume":"22","author":"M Kearney","year":"2008","journal-title":"Aids"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.","volume":"43","author":"S Palmer","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref33","first-page":"148","article-title":"Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.","volume":"8","author":"G Hache","year":"2006","journal-title":"AIDS Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1073\/pnas.0710190105","article-title":"Cytidine deamination induced HIV-1 drug resistance.","volume":"105","author":"LC Mulder","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1000367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:32:29Z","timestamp":1589005949000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1000367"}},"subtitle":[],"editor":[{"given":"Jeremy","family":"Luban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,3]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1000367","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,3]]}}}